The slip
PARKINSON RECEIPTno. 4587
20 Oct 2026, 20:52 UTCdopamine neurons, braak
predictionSLC24A4 in dopamine neurons tracks Braak Lewy-body stage
registeredb256afca31bc354d
discovery+0.16 p=0.680 n=9
replication-0.36 p=0.344 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.16, p 0.680)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTef2308bfb9d9a881ab5498c5…
follows 9f4817fff682…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4587: SLC24A4 in dopamine neurons, braak
- power
- full sample -0.23 (p 0.360, n 18), 95% CI -0.63 to +0.27. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.18 (p 0.482, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.40 (p 0.101, n 18). could be the mix.
- skeptic
- leave-one-out range -0.37 to -0.14, sign flips 0; without severely affected donors -0.23 (p 0.360, n 18). fragile.
- cell type
- strongest in OPCs: -0.60 (p 0.0089, n 18) vs -0.23 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC24A4 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SLC24A4 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.20 p 0.477 (needs p < 4.4e-4)